Childhood Cancer
Conditions
Keywords
childhood cancer survivors, electronic medical record, sensory deficit screening, hearing loss, peripheral neuropathy, vestibular, vision
Brief summary
The overall goal of this study is to attempt to overcome the organizational barriers that impede prompt screening for at-risk sensory deficits in childhood cancer survivors (CCS). Using a cross sectional design study, collaborators in the Informatics Research branch of the Institute of Informatics at the Washington University School of Medicine will identify CCS at risk for sensory deficits based upon their therapy exposure to generate the highlighting patients at risk for sensory screening (HPARSS) document. The investigators will utilize the HPARSS that will link therapy related risks for sensory deficits to specific screening procedures prompting the primary oncology provider to implement screening, diagnostic testing, and therapy.
Interventions
OTHERHighlighting Patients at Risk for Sensory Screening (HPARSS)
Collaborators in the Informatics Research branch of the Institute of Informatics at the Washington University School of Medicine will identify CCS at risk for sensory deficits based upon their therapy exposure to generate the HPARSS document.
Sponsors
Washington University School of Medicine
St. Jude Children's Research Hospital
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
7 Years to 17 Years
Healthy volunteers
No
Inclusion criteria
* Patients with a diagnosis of pediatric cancer (diagnosis at \<18 years of age) * Treatment including chemotherapy and/or radiation therapy * Completion of all cancer therapy for at least 6 months and less than 2 years * Followed in the Division of Pediatric Hematology/Oncology Program at the Washington University School of Medicine * Current age between 7 and 17 years of age (age where all of the screening tests are both valid and have been successfully performed by our group) * English speaking
Exclusion criteria
* Undergoing active cancer treatment * Patient under the care of the Late Effects Program at St. Louis Children's Hospital * Received previous diagnostic testing or rehabilitative therapy for a secondary deficit eligible for screening. * Parents and/or patient illiteracy * No contact with treatment team in the past two years * In foster care or without a legal guardian
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of patients with at risk for sensory deficits identified by HPARSS | Through completion of enrollment for all patients (estimated to be 9 months) |
| Percentage of at risk patients who fail the assigned screening test | Through completion of enrollment for all patients (estimated to be 9 months) |
| Percentage of patients in need of referral for screen test results who participate in formal diagnostic testing and/or treatment | Through 1 year after the completion of screening test for all participants (estimated to be 1 year and 9 months) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number and types of barriers to participation in formal diagnostic testing and therapy in CCS failing to engage in sensory screening | At approximately 2 months following the patient's screening | — |
| Number and types of facilitators to participation in formal diagnostic testing and therapy in CCS failing to engage in sensory screening | At approximately 2 months following the patient's screening | — |
| Acceptability of HPARSS as measured by the Acceptability of Intervention Measure (AIM) | To be completed at the time of enrollment completion (approximately 9 months) | -4 questions inquiring about the acceptability of HPARSS with answers ranging from completely disagree=1 to completely agree=5. The higher the score indicates higher acceptability of the HPARSS. |
| Feasibility of intervention as measured by Feasibility of Intervention Measure (FIM) | To be completed at the time of enrollment completion (approximately 9 months) | -4 questions inquiring about the feasibility of HPARSS with answers ranging from completely disagree=1 to completely agree=5. The higher the score indicates higher feasibility of the HPARSS. |
Countries
United States
Contacts
CONTACTRobert J Hayashi, M.D.
PRINCIPAL_INVESTIGATORRobert J Hayashi, M.D.
Washington University School of Medicine
Outcome results
None listed